The FDA is reminding healthcare professionals and patients that some stolen vials of Levemir (insulin detemir [rDNA origin], from Novo Nordisk), a long-acting insulin, may still be on the market. In June 2009, the FDA announced that three lots (129,000 vials) of Levemir insulin 10mL vials were taken in the theft and are identifiable by the following lot numbers: XZF0036, XZF0037, and XZF0038. Evidence gathered suggests that the stolen insulin was not stored and handled properly and thus, may be dangerous for patient use. The FDA is advising patients to check their personal supply and not to use their Levemir insulin if it comes from one of the stolen lots. The lot numbers can be found on the side of the box of insulin or on the side of the vial.
Only about 2% of the total amount stolen has been recovered. The FDA continues to investigate this matter and is asking for any information regarding these vials to the FDA’s Office of Criminal Investigations (OCI) by calling (800) 551-3989 or by visiting the OCI Web site.
For more information visit www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166359.htm.